Purpose of the Procedure
- Monitor tumor progression without invasive surgery
- Evaluate patient response to chemotherapy or targeted therapy
- Early detection of recurrence before clinical symptoms appear
Monitor cancer mutations and treatment response with high precision using our advanced Liquid Biopsy. This non-invasive blood test detects ctDNA and CTCs, providing critical insights for personalized oncology care.
Scientific name: Liquid Biopsy for Solid Tumors
An advanced diagnostic test that analyzes circulating tumor DNA (ctDNA) in the blood. It monitors genetic mutations and treatment efficacy for solid tumors, offering a non-invasive alternative to traditional biopsies.